Background And Purpose: DWI infarcts involving the bilateral anterior and posterior circulation suggest an embolic etiology. In the absence of an identifiable embolic source, we analyzed DWI lesions involving these 3 cerebral territories to determine the diagnostic value for ischemic infarction caused by cancer-associated hypercoagulation.

Materials And Methods: A retrospective analysis of all brain MR imaging studies at our institution from July 2014 to June 2015 was conducted, yielding 4075 studies. Of those, 17% ( = 709) contained the terms "restricted-diffusion" plus either "numerous," "innumerable," "multiple," or "bilateral." Of these 709 reports, 6% ( = 41) of DWI lesions involving 3 or more vascular territories of the bilateral anterior and posterior circulation were analyzed.

Results: Of the 41 patients, 19 separate etiologies were identified, the most frequent being malignancy-related infarctions (22% [ = 9]) and hypoxic-ischemic injury (12% [ = 5]). Only 2 patients had an indeterminate etiology. The most frequent etiology of infarctions not suspected clinically or radiographically was malignancy ( < .001). Infarctions of malignancy had a characteristic appearance, being nonenhancing, nonring-appearing clusters or single areas of restricted diffusion of 0.5-2 cm with a peripheral location or larger vascular territories, uncommonly in a watershed distribution, and with absence of diffuse cortical ribbon or deep gray nuclei involvement.

Conclusions: Approximately 1 in 5 ischemic infarcts in patients with DWI lesions involving 3 vessel territories are malignancy related. In the absence of an identifiable embolic source, ischemic infarction with cancer-associated hypercoagulation accounts for 75% of cases. Cancer-associated hypercoagulation infarction should be considered, particularly when no other cause is apparent.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963789PMC
http://dx.doi.org/10.3174/ajnr.A4846DOI Listing

Publication Analysis

Top Keywords

cancer-associated hypercoagulation
12
dwi lesions
12
lesions involving
12
bilateral anterior
8
anterior posterior
8
posterior circulation
8
absence identifiable
8
identifiable embolic
8
embolic source
8
ischemic infarction
8

Similar Publications

Background:  Thromboembolism is the second leading cause of death among patients with non-small cell lung cancer (NSCLC), but the precise mechanisms of thrombogenesis in NSCLC remain largely unknown. Our objectives were to evaluate the definitive role of neutrophil extracellular traps (NETs) in the hypercoagulability in NSCLC and to explore its interactions with platelets and endothelial cells (ECs).

Methods:  The levels of NET markers in samples from 100 NSCLC patients and 30 healthy controls were measured by ELISA.

View Article and Find Full Text PDF

The subject of this guideline from the Institute of Family Medicine at the University of Zurich (IHAMZ) is the management of venous thrombosis. The review summarizes the current evidence and recommendations from international guidelines (1-6). The IHAMZ-guidelines focus on primary care, they also provide guidance on the coordination of general and specialist medical care as well as on the transition between outpatient and hospital care taking into account the special features of the Swiss healthcare system.

View Article and Find Full Text PDF

Cancer is not a guest.

Transl Oncol

January 2025

Department of Medical Sciences and Public Health, University of Cagliari, 09100 Cagliari, Italy.

In a recent article titled "Embracing Cancer Complexity: Hallmarks of Systemic Disease" published in Cell, Swaton et al. propose the idea of cancer as a guest that develops within a host. They discuss the possible causes and events of neoplastic cell dysregulations within an organism, highlighting events such as cachexia and thrombosis.

View Article and Find Full Text PDF

The effects of an aggressive breast tumor on thrombosis after antithrombin downregulation in a hypercoagulable mouse model.

Thromb Res

December 2024

Einthoven Laboratory for Vascular and Regenerative Medicine, Division of Thrombosis and Hemostasis, Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands. Electronic address:

Background: Despite improvements in therapy, breast cancer still contributes to high mortality rates. Survival of these patients becomes progressively worse upon diagnosis with cancer-associated thrombosis (CAT). Unfortunately, the mechanism causing CAT has remained unclear.

View Article and Find Full Text PDF
Article Synopsis
  • * Current research focuses on various mechanisms contributing to this hypercoagulability, including the release of coagulation-promoting substances by tumor cells and their interaction with the fibrinolytic system and platelets.
  • * Understanding these mechanisms is crucial for developing new drugs and treatment strategies to improve patient outcomes and survival rates.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!